Sustainability | July 20, 2022
Essential Pharma progress in its ESG performance
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems
The award places the company in the top 5% globally
Recognition places pharmaceutical excipients leader among the top 5% of companies globally, highlighting progress in emissions reduction, responsible sourcing, and sustainable supply chain practices
Report highlights growing confidence in digitalisation and AI, even as healthcare leaders remain concerned about workforce gaps, cybersecurity, and data readiness
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
